Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -252.84 |
peg ratio | -31.25 |
price to book ratio | 7.76 |
price to sales ratio | 11.41 |
enterprise value multiple | 240.74 |
price fair value | 7.76 |
profitability ratios | |
---|---|
gross profit margin | 86.1% |
operating profit margin | -2.96% |
pretax profit margin | 2.45% |
net profit margin | -4.52% |
return on assets | -2.16% |
return on equity | -2.88% |
return on capital employed | -1.72% |
liquidity ratio | |
---|---|
current ratio | 2.47 |
quick ratio | 2.20 |
cash ratio | 1.32 |
efficiency ratio | |
---|---|
days of inventory outstanding | 267.19 |
operating cycle | 327.40 |
days of payables outstanding | 97.94 |
cash conversion cycle | 229.46 |
receivables turnover | 6.06 |
payables turnover | 3.73 |
inventory turnover | 1.37 |
debt and solvency ratios | |
---|---|
debt ratio | 0.08 |
debt equity ratio | 0.11 |
long term debt to capitalization | 0.00 |
total debt to capitalization | 0.10 |
interest coverage | -8.18 |
cash flow to debt ratio | -0.49 |
cash flow ratios | |
---|---|
free cash flow per share | -4.51 |
cash per share | 25.29 |
operating cash flow per share | -3.27 |
free cash flow operating cash flow ratio | 1.38 |
cash flow coverage ratios | -0.49 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | -2.62 |
Frequently Asked Questions
Vertex Pharmaceuticals Incorporated (VRTX) published its most recent earnings results on 05-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)'s trailing twelve months ROE is -2.88%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Vertex Pharmaceuticals Incorporated (VRTX) currently has a ROA of -2.16%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
VRTX reported a profit margin of -4.52% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.47 in the most recent quarter. The quick ratio stood at 2.20, with a Debt/Eq ratio of 0.11.